Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-based genetic testing for Women's cancer prevention.

Best practice & research. Clinical obstetrics & gynaecology - 1 May 2020

Evans Olivia, Gaba Faiza, Manchanda Ranjit

Abstract excerpt

Germline mutations in cancer-susceptibility-genes (CSG) can dramatically increase womens' lifetime risk of ovarian, endometrial, breast and bowel cancers. Identification of unaffected carriers is important to enable proactive engagement with highly effective screening and preventive options to minimise cancer risk. Currently, a family-history model is used to identify individuals with CSGs. Complex regional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Colorectal Neoplasms, Hereditary Nonpolyposis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Neoplasms

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 32245629
DOI: 10.1016/j.bpobgyn.2020.02.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-based genetic testing for Women's cancer prevention.PMID 32245629Read ↗

Population-based Genetic Testing for Precision Prevention.Semantic proximity Read ↗

Population Based Testing for Primary Prevention: A Systematic ReviewSemantic proximity Read ↗

Genetic screening for gynecological cancer: where are we heading?Semantic proximity Read ↗

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.Semantic proximity Read ↗

Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidence.Semantic proximity Read ↗

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.Semantic proximity Read ↗

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.Semantic proximity Read ↗

Clinical implications of BRCA1 genetic testing for Ashkenazi-Jewish women.Semantic proximity Read ↗

Population‐based genetic testing for cancer susceptibility genes: quo vadis?Semantic proximity Read ↗

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.Semantic proximity Read ↗

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.Semantic proximity Read ↗

Genetic Counselling Needs for Reproductive Genetic Carrier Screening: A Scoping ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.